NCT04190589 Prospective Study of Extended Robotic Right Hemicolectomy With Complete Mesocolic Excision for Cancer
| NCT ID | NCT04190589 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vejle Hospital |
| Condition | Colorectal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2020-05-18 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2020-05-18 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A single-center prospective study to elucidate whether extended robot-assisted right colectomy (e-RARC) performs as well as extended open right colectomy (e-ORC) in terms of specimen quality, and in addition, whether less postoperative morbidity and shorter length of stay (LOS) can be attained. Patients with colonic cancer near the right flexure or the oral part of the transverse colon will be compared excluding the most technically demanding and frail patients in both groups. A total of 40 patients undergoing e-RARC in a prospective series will be included and compared with 44 consecutive patients previously treated with e-ORC.
Eligibility Criteria
Inclusion Criteria: * Suspected or verified colonic cancer visualized by colonoscopy and on CT in the anal part of the ascending colon, in the right flexure or in the oral 2/3 of the transverse colon * Patient is 18 years or older, legally competent and able to comprehend information and give consent * Tumor is UICC stage I-III on preop CT * Operation is elective Exclusion Criteria: * Previous major open intraabdominal surgery * Ileus or other acute abdominal condition * CT scan with suspicion of T4 tumor * RITA score \> 3 (Preop risk and frailty score) * BMI \> 35 kg/m2 * Project surgeon not available
Contact & Investigator
Lars Bundgaard, MD
PRINCIPAL INVESTIGATOR
Department of Surgery
Frequently Asked Questions
Who can join the NCT04190589 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04190589 currently recruiting?
Yes, NCT04190589 is actively recruiting participants. Contact the research team at hans.rahr@rsyd.dk for enrollment information.
Where is the NCT04190589 trial being conducted?
This trial is being conducted at Vejle, Denmark.
Who is sponsoring the NCT04190589 clinical trial?
NCT04190589 is sponsored by Vejle Hospital. The principal investigator is Lars Bundgaard, MD at Department of Surgery. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.